Clinipace

Great news for our employees, partners, and clients.  Today we were named one of 25 North Carolina Companies to Watch by CED, a private, nonprofit organization that promotes entrepreneurial efforts in North Carolina. The inaugural class of North Carolina Companies to Watch represent growth-stage entrepreneurial companies that demonstrate high performance in the marketplace, exhibit innovative products or display other unique qualities that make them “worth watching.”

The North Carolina Companies to Watch were selected from an initial pool of 190 nominees from across North Carolina. They are privately held companies of between 6-99 employees and $1 million to $50 million in annual revenue or funds raised from grants, investors or partnerships. The winners represent the geographic regions of the state as well as different sectors of the economy.

Full press release

Mark Shapiro, our director of clinical solutions, will participate on a CED’s Biotech Forum panel tomorrow evening (September 16th, 2009) at the North Carolina Biotechnology Center. The seminar entitled “Meeting Clinical Development Objectives in Today’s Economic Environment” is hosted by CED.

Mark will discuss how to “Cost-Effectively Manage Clinical Trials”. Join us if you can.

To register

http://www.cednc.org/event/207